ホーム > 鈴木 裕之/ Suzuki, Hiroyuki

鈴木 裕之

ALUMNI 2026年7月現在、筑波大学が主たる所属機関ではありません

Suzuki, Hiroyuki

東北大学 , 大学院医学系研究科 , 准教授
Tohoku University , Graduate School of Medicine , Associate Professor

http://www.md.tsukuba.ac.jp/epatho/

http://www.md.tsukuba.ac.jp/younginit/

シグナル伝達の異常に起因した疾患 を治療する創薬開発に向けた研究
シグナル伝達と疾患リサーチユニット
Research for drug discovery to treat diseases caused by abnormal cellular signaling

2017-05-16

金保 安則 加藤 光保 熊谷 嘉人 高橋 智 渋谷 彰 渋谷 和子 入江 賢児 鈴木 裕之 船越 祐司 新開 泰弘
  1. 1. Epitope Mapping of Anti-mouse ACKR4 Monoclonal Antibodies Developed by N-Terminal Peptide Immunization. Miu Hirose; Tomohiro Tanaka; Miyuki Yanaka; Takuro Nakamura (+2 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 21679436261461702 (2026) Semantic Scholar
  2. 2. Epitope Mapping of Anti-Mouse C-C Motif Chemokine Receptor 1 Monoclonal Antibodies Developed by the Cell-Based Immunization and Screening Method. Ayaka Okada; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 21679436261459606 (2026) Semantic Scholar
  3. 3. Establishment of a Novel Anti-EphA4 Monoclonal Antibody, Ea4Mab-3, for Versatile Applications. Ayano Saga; Guanjie Li; Tomohiro Tanaka; Mika K Kaneko (+1 著者) Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 21679436261450334 (2026) Semantic Scholar
  4. 4. Ca13Mab-17, a Novel Anti-Cadherin-13 Monoclonal Antibody for Versatile Applications. Kai Shimizu; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Antibodies (Basel, Switzerland) 15: (2026) Semantic Scholar
  5. 5. Chimeric Anti-Glypican 1 Antibodies Exert Antitumor Activities in Xenograft Models of Lung and Pancreatic Cancers. Haruto Yamamoto; Hiroyuki Suzuki; Tomokazu Ohishi; Hiroyuki Satofuka (+1 著者) Yukinari Kato
      International journal of molecular sciences 27: (2026) Semantic Scholar
  6. 6. Development of Highly Sensitive and Specific Monoclonal Antibodies Against Glypican-1 Using the Cell-Based Immunization and Screening Technology Haruto Yamamoto; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K. KanekoYukinari Kato
      International Journal of Translational Medicine 6: 18 (2026) Semantic Scholar
  7. 7. A Novel Anti-CDH5/VE-Cadherin Monoclonal Antibody (Ca5Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry. Haruto Yamamoto; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 21679436261441142 (2026) Semantic Scholar
  8. 8. Antitumor Activities of Chimeric Anti-EphA2 Antibodies in Xenograft Models of Breast, Pancreatic, and Colorectal Cancers. Guanjie Li; Hiroyuki Suzuki; Tomokazu Ohishi; Hiroyuki Satofuka (+11 著者) Yukinari Kato
      International journal of molecular sciences 27: (2026) Semantic Scholar
  9. 9. A Novel Anti-Cadherin-19 Monoclonal Antibody (Ca19Mab-8) for Flow Cytometry, Western Blotting, and Immunohistochemistry. Guanjie Li; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Current issues in molecular biology 48: (2026) Semantic Scholar
  10. 10. Development of Anti-Human Cadherin-26 Monoclonal Antibody, Ca26Mab-6, for Flow Cytometry. Hiroyuki Satofuka; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 21679436261428408 (2026) Semantic Scholar
  11. 11. Development of novel anti-CDH1/E-cadherin monoclonal antibodies for versatile applications. Rena Ubukata; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Biochemistry and biophysics reports 45: 102401 (2026) Semantic Scholar
  12. 12. Cx2Mab-5: A Novel Anti-Mouse CXCR2 Monoclonal Antibody Developed by N-Terminus Peptide Immunization for Multiple Applications. Honoka Taruta; Tomohiro Tanaka; Mika K Kaneko; Hiroyuki SuzukiYukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy 21679436251415261 (2026) Semantic Scholar
  13. 13. Establishment of Novel Anti-EphB3 Monoclonal Antibodies for Multiple Applications. Guanjie Li; Hiroyuki Suzuki; Mika K Kaneko; Yukinari Kato
      Monoclonal antibodies in immunodiagnosis and immunotherapy (2025) Semantic Scholar
  14. 14. Epitope analysis of an anti-mouse CCR1 monoclonal antibody S15040E using flow cytometry. Ayaka Okada; Hiroyuki Suzuki; Takao Arimori; Tomohiro Tanaka (+1 著者) Yukinari Kato
      Biochemistry and biophysics reports 44: 102265 (2025) Semantic Scholar
  15. 15. Therapeutic Potential of an Anti-CD44v6 Monoclonal Antibody in Xenograft Models of Colorectal and Gastric Cancer. Aoi Hirayama; Tomohiro Tanaka; Tomokazu Ohishi; Keisuke Shinoda (+7 著者) Yukinari Kato
      Cells 14: (2025) Semantic Scholar
  16. 16. Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy. Tomokazu Ohishi; Hiroyuki Suzuki; Mika K Kaneko; Tomohiro Tanaka (+4 著者) Manabu Kawada
      Cancer science 116: 3417 (2025) Semantic Scholar
  17. 17. Antitumor Activity by an Anti-CD44 Variant 9 Monoclonal Antibody in Gastric and Colorectal Cancer Xenograft Models. Mayuki Tawara; Hiroyuki Suzuki; Tomokazu Ohishi; Mika K KanekoYukinari Kato
      International journal of molecular sciences 26: (2025) Semantic Scholar
  18. 18. PMab-322: a novel anti-hippopotamus podoplanin monoclonal antibody for multiple applications. Haruto Yamamoto; Hiroyuki Suzuki; Tomohiro Tanaka; Mika K KanekoYukinari Kato
      Biochemistry and biophysics reports 43: 102170 (2025) Semantic Scholar
  19. 19. Development of a novel anti-human glypican 5 monoclonal antibody (G5Mab-1) for multiple applications. Yu Kaneko; Tomohiro Tanaka; Shiori Fujisawa; Guanjie Li (+3 著者) Yukinari Kato
      Biochemistry and biophysics reports 43: 102140 (2025) Semantic Scholar
  20. 20. Development of a specific anti-human EphA3 monoclonal antibody, Ea3Mab-20, for flow cytometry. Hiroyuki Satofuka; Hiroyuki Suzuki; Miu Hirose; Keisuke Shinoda (+3 著者) Yukinari Kato
      Biochemistry and biophysics reports 43: 102130 (2025) Semantic Scholar
1 2 3 … 11
  1. 1. あなたのラボから薬を生み出すアカデミア創薬の実践 : all Japan体制の先端技術支援を利用した創薬の最前線 善光, 龍哉; 辻川, 和丈 (担当:分担執筆, 範囲:CBIS法による高感度抗体の作製)
    羊土社 2024年2月 (ISBN: 9784758104166)
  2. 2. がんゲノム医療時代の分子腫瘍学 鈴木裕之; 後藤のはら; 加藤光保 (担当:分担執筆, 範囲:TGF-β経路)
    文光堂 2022年4月
  3. 3. 炎症メディエーター TGF-β 鈴木,裕之; 青山,知恵; 加藤,光保 (担当:共著)
    日本臨床 2009年5月
  4. 4. TGF-betaシグナル伝達系とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:監修)
    南山堂 2008年9月
  5. 5. TGF-βシグナル伝達とがん治療 鈴木裕之; 中条友香; 加藤光保 (担当:分担執筆)
    がんの分子標的治療 2008年6月
  6. 6. Negative regulation of the TGF-β family signal pathway by inhibitory Smads and their involvement in cancer and fibrosis. Itoh S; Suzuki H; Itoh F; Miyazono K; Kato M (担当:共著)
    Humana Press Inc. 2008年
  7. 7. IGFBP 鈴木裕之; 加藤光保 (担当:監修)
    サイトカイン・増殖因子用語ライブラリー / 羊土社 2005年3月
  8. 8. TGF-betaシグナルと疾患 鈴木裕之; 宮園浩平 (担当:監修)
    シグナル伝達研究2003 シグナル伝達研究2003 羊土社 2003年1月

 770 total views